These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 760895)

  • 21. Hormonal control of uteroglobin secretion in rabbit uterus: inhibition of uteroglobin synthesis and messenger ribonucleic acid accumulation by oestrogen and anti-oestrogen administration.
    Kopu HT; Hemminki SM; Torkkeli TK; Jänne OA
    Biochem J; 1979 Jun; 180(3):491-500. PubMed ID: 486127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nuclear binding of oestradiol-17beta and induction of protein synthesis in the rat uterus during postnatal development.
    Sömjen D; Sömjen G; King RJ; Kaye AM; Lindner HR
    Biochem J; 1973 Sep; 136(1):25-33. PubMed ID: 4772625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Estrogen- and antiestrogen-induced ornithine decarboxylase activity and uterine growth in the rat.
    Branham WS; Leamons ML; Sheehan DM
    J Steroid Biochem; 1988 Feb; 29(2):153-9. PubMed ID: 3347055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autoradiographic localization of [3H]hydroxytamoxifen to uterine oestrogen- and antioestrogen-binding sites.
    Ennis BW; Stumpf WE
    Histochem J; 1989 Jan; 21(1):52-60. PubMed ID: 2745159
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies on the activation of the oestrogen receptor bound to the anti-oestrogens 4-hydroxytamoxifen and ICI 164,384 by using three monoclonal antibodies.
    Giambiagi N; Pasqualini JR
    J Mol Endocrinol; 1991 Aug; 7(1):9-19. PubMed ID: 1892545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological characterization of a novel oestrogen antagonist, ZK 119010, in rats and mice.
    Nishino Y; Schneider MR; Michna H; von Angerer E
    J Endocrinol; 1991 Sep; 130(3):409-14. PubMed ID: 1834757
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Steroidal pure antioestrogens.
    Wakeling AE; Bowler J
    J Endocrinol; 1987 Mar; 112(3):R7-10. PubMed ID: 3559447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of mepyramine and ranitidine on the oestrogen and anti-oestrogen stimulated rat uterus.
    Marshall K; Senior J
    Br J Pharmacol; 1986 Sep; 89(1):251-6. PubMed ID: 3801774
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interference of gestagens and androgens with rat uterine oestrogen receptors.
    Di Carlo F; Conti G; Reboani C
    J Endocrinol; 1978 Apr; 77(1):49-55. PubMed ID: 147913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction of the radiolabelled high-affinity anti-oestrogen [3H]H1285 with the cytoplasmic oestrogen receptor.
    Keene JL; Sweet F; Ruh MF; Ruh TS
    Biochem J; 1984 Feb; 217(3):819-26. PubMed ID: 6712598
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antioestrogenic and antitumour activities of a series of non-steroidal antioestrogens.
    Wakeling AE; Valcaccia B
    J Endocrinol; 1983 Dec; 99(3):455-64. PubMed ID: 6644236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of protamine to study [6,7-3H] oestradiol-17-beta binding in rat uterus.
    Steggles AW; King RJ
    Biochem J; 1970 Aug; 118(5):695-701. PubMed ID: 4248960
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dynamics of oestrogen-receptor distribution between the cytosol and nuclear fractions of immature rat uterus after oestradiol administration.
    Mester J; Baulieu EE
    Biochem J; 1975 Mar; 146(3):617-23. PubMed ID: 167724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stimulatory and inhibitory effects of estrogen on uterine DNA synthesis.
    Stormshak F; Leake R; Wertz N; Gorski J
    Endocrinology; 1976 Dec; 99(6):1501-11. PubMed ID: 1001250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tamoxifen as an anti-tumour agent: effect on oestrogen binding.
    Jordan VC; Dowse LJ
    J Endocrinol; 1976 Feb; 68(02):297-303. PubMed ID: 176295
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-affinity anti-oestrogen binding site distinct from the oestrogen receptor.
    Sutherland RL; Murphy LC; San Foo M; Green MD; Whybourne AM; Krozowski ZS
    Nature; 1980 Nov; 288(5788):273-5. PubMed ID: 7432524
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro effects of oestradiol on galanin gene expression in rat anterior pituitary cells.
    Ponchon M; Lause P; Maiter D
    J Neuroendocrinol; 2000 Jun; 12(6):559-64. PubMed ID: 10844585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Study of the in-vivo antioestrogenic action of N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine HCl (DPPE), a novel intracellular histamine antagonist and antioestrogen binding site ligand.
    Brandes LJ; Hogg GR
    J Reprod Fertil; 1990 May; 89(1):59-67. PubMed ID: 2374133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Xeno-oestrogens and phyto-oestrogens induce the synthesis of leukaemia inhibitory factor by human and bovine oviduct cells.
    Reinhart KC; Dubey RK; Keller PJ; Lauper U; Rosselli M
    Mol Hum Reprod; 1999 Oct; 5(10):899-907. PubMed ID: 10508216
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-oestrogen action: uterine nuclear retention of the CI-628 anti-oestrogen receptor complex in vitro.
    Rinehart JS; Ruh TS; Ruh MF
    Acta Endocrinol (Copenh); 1977 Feb; 84(2):367-73. PubMed ID: 576349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.